Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies.

Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, Ferri M, Pastor-Barriuso R.

BMJ. 2017 Apr 26;357:j1550. doi: 10.1136/bmj.j1550. Review.

2.

Monitoring quality and coverage of harm reduction services for people who use drugs: a consensus study.

Wiessing L, Ferri M, Běláčková V, Carrieri P, Friedman SR, Folch C, Dolan K, Galvin B, Vickerman P, Lazarus JV, Mravčík V, Kretzschmar M, Sypsa V, Sarasa-Renedo A, Uusküla A, Paraskevis D, Mendão L, Rossi D, van Gelder N, Mitcheson L, Paoli L, Gomez CD, Milhet M, Dascalu N, Knight J, Hay G, Kalamara E, Simon R; EUBEST working group, Comiskey C, Rossi C, Griffiths P.

Harm Reduct J. 2017 Apr 22;14(1):19. doi: 10.1186/s12954-017-0141-6.

3.

Rapid Decline in HIV Incidence Among Persons Who Inject Drugs During a Fast-Track Combination Prevention Program After an HIV Outbreak in Athens.

Sypsa V, Psichogiou M, Paraskevis D, Nikolopoulos G, Tsiara C, Paraskeva D, Micha K, Malliori M, Pharris A, Wiessing L, Donoghoe M, Friedman S, Jarlais DD, Daikos G, Hatzakis A.

J Infect Dis. 2017 May 15;215(10):1496-1505. doi: 10.1093/infdis/jix100.

PMID:
28407106
4.

HCV prevalence and risk behaviours among injectors of new psychoactive substances in a risk environment in Hungary-An expanding public health burden.

Tarján A, Dudás M, Wiessing L, Horváth G, Rusvai E, Tresó B, Csohán Á.

Int J Drug Policy. 2017 Mar;41:1-7. doi: 10.1016/j.drugpo.2016.11.006. Epub 2016 Dec 13.

PMID:
27984762
5.

Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.

Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, El-Bassel N, Dolan K, Moazen B, Wirtz AL, Verster A, Altice FL.

Lancet. 2016 Sep 10;388(10049):1115-1126. doi: 10.1016/S0140-6736(16)30769-3. Epub 2016 Jul 14. Review.

PMID:
27427456
6.

High Prevalence and Incidence of HIV and HCV Among New Injecting Drug Users With a Large Proportion of Migrants--Is Prevention Failing?

Folch C, Casabona J, Espelt A, Majó X, Meroño M, Gonzalez V, Wiessing L, Colom J, Brugal MT; REDAN Study Group.

Subst Use Misuse. 2016 Jan 28;51(2):250-60. doi: 10.3109/10826084.2015.1092991. Epub 2016 Jan 28.

PMID:
26820260
7.

Cannabis: monitor policy changes.

Wiessing L, Hughes B, Ferri M, Griffiths P, Des Jarlais D.

Nature. 2015 Nov 19;527(7578):305. doi: 10.1038/527305d. No abstract available.

PMID:
26581279
8.

Design and baseline findings of a large-scale rapid response to an HIV outbreak in people who inject drugs in Athens, Greece: the ARISTOTLE programme.

Hatzakis A, Sypsa V, Paraskevis D, Nikolopoulos G, Tsiara C, Micha K, Panopoulos A, Malliori M, Psichogiou M, Pharris A, Wiessing L, van de Laar M, Donoghoe M, Heckathorn DD, Friedman SR, Des Jarlais DC.

Addiction. 2015 Sep;110(9):1453-67. doi: 10.1111/add.12999. Epub 2015 Jul 14.

9.

Increasing prevalence of HIV infection among first time clients in Italian drug treatment services - is it sexual transmission?

Cruciani M, Wiessing L, Serpelloni G, Genetti B, Andreotti A, Iulia C, Zermiani M, Suligoi B.

BMC Infect Dis. 2015 Apr 30;15:201. doi: 10.1186/s12879-015-0940-x.

10.
11.

Roundtable discussion: how lessons learned from HIV can inform the global response to viral hepatitis.

Lazarus JV, Lundgren J, Casabona J, Wiessing L, Matheï C, Vickerman P, Prins M, Kretzschmar M, Kantzanou M, Giraudon I, Ferri M, Griffiths P, Harris M, Walker M, Chavdarova L, Schatz E, Schiffer K, Kools J, Farell J, Mendão L.

BMC Infect Dis. 2014;14 Suppl 6:S18. doi: 10.1186/1471-2334-14-S6-S18. Epub 2014 Sep 19. No abstract available.

12.

A systematic review of Hepatitis C virus treatment uptake among people who inject drugs in the European Region.

Lazarus JV, Sperle I, Maticic M, Wiessing L.

BMC Infect Dis. 2014;14 Suppl 6:S16. doi: 10.1186/1471-2334-14-S6-S16. Epub 2014 Sep 19. Review.

13.

Trajectories of injecting behavior in the Amsterdam Cohort Study among drug users.

Mikolajczyk RT, Horn J, Prins M, Wiessing L, Kretzschmar M.

Drug Alcohol Depend. 2014 Nov 1;144:141-7. doi: 10.1016/j.drugalcdep.2014.08.020. Epub 2014 Sep 6.

PMID:
25248472
14.

Self-reported testing, HIV status and associated risk behaviours among people who inject drugs in Europe: important differences between East and West.

Uusküla A, Raag M, Folch C, Prasad L, Karnite A, van Veen MG, Eritsyan K, Rosinska M, Des Jarlais DC, Wiessing L.

AIDS. 2014 Jul 17;28(11):1657-64. doi: 10.1097/QAD.0000000000000299.

PMID:
25232900
15.

Hepatitis C virus infection epidemiology among people who inject drugs in Europe: a systematic review of data for scaling up treatment and prevention.

Wiessing L, Ferri M, Grady B, Kantzanou M, Sperle I, Cullen KJ; EMCDDA DRID group, Hatzakis A, Prins M, Vickerman P, Lazarus JV, Hope VD, Matheï C.

PLoS One. 2014 Jul 28;9(7):e103345. doi: 10.1371/journal.pone.0103345. eCollection 2014. Review.

16.

Homelessness and Other Risk Factors for HIV Infection in the Current Outbreak Among Injection Drug Users in Athens, Greece.

Sypsa V, Paraskevis D, Malliori M, Nikolopoulos GK, Panopoulos A, Kantzanou M, Katsoulidou A, Psichogiou M, Fotiou A, Pharris A, Van De Laar M, Wiessing L, Jarlais DD, Friedman SR, Hatzakis A.

Am J Public Health. 2015 Jan;105(1):196-204.

17.

Human immunodeficiency virus among people who inject drugs: is risk increasing in Europe?

Hedrich D, Kalamara E, Sfetcu O, Pharris A, Noor A, Wiessing L, Hope V, Van de Laar M.

Euro Surveill. 2013 Nov 28;18(48):20648.

18.

Economic recession and emergence of an HIV-1 outbreak among drug injectors in Athens metropolitan area: a longitudinal study.

Paraskevis D, Nikolopoulos G, Fotiou A, Tsiara C, Paraskeva D, Sypsa V, Lazanas M, Gargalianos P, Psichogiou M, Skoutelis A, Wiessing L, Friedman SR, Jarlais DC, Terzidou M, Kremastinou J, Malliori M, Hatzakis A.

PLoS One. 2013 Nov 12;8(11):e78941. doi: 10.1371/journal.pone.0078941. eCollection 2013.

19.

The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.

Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M.

J Viral Hepat. 2013 Aug;20 Suppl 2:1-20. doi: 10.1111/jvh.12120. Erratum in: J Viral Hepat. 2013 Oct;20(10):744. Hadjichristodoulou, T [corrected to Hadjichristodoulou, C].

PMID:
23827008
20.

Hepatitis C among injecting drug users is two times higher in Stockholm, Sweden than in Rotterdam, the Netherlands.

Norden L, van Veen M, Lidman C, Todorov I, Guarita B, Kretzschmar M, Wiessing L.

Subst Use Misuse. 2013 Dec;48(14):1469-74. doi: 10.3109/10826084.2013.793356. Epub 2013 Jun 10.

PMID:
23750711

Supplemental Content

Loading ...
Support Center